Clinical severity and epithelial endotypes in chronic rhinosinusitis. Issue 2 (4th October 2012)

• Record Type: Journal Article
• Authors: Lam, Matthew; Hull, Laura; McLachlan, Rohan; Snidvongs, Kornkiat; Chin, David; Pratt, Ellie; Kalish, Larry; Sacks, Raymond; Earls, Peter; Sewell, William; Harvey, Richard J.
• Is Part Of: International forum of allergy & rhinology. Volume 3:Issue 2(2013:Feb.)
• Page Start: 121
• Page End: 128
• Publication Date: 2012-10-04
• Subjects: 617.51005
• DOI: 10.1002/alr.21082
• Languages: English
• ISSNs: 2042-6976

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="alr21082-sec-0010" sec-type="section"> <title>Background</title> <p>Chronic rhinosinusitis (CRS) is a heterogeneous disease defined by epithelial inflammation. The link between measures of traditional disease severity and markers of epithelial inflammation is poorly understood as prior research has focused on presence of polyps or degree of eosinophilia. The expression of 3 epithelial derived cytokines implicated in initiation of T‐helper 2 (Th2) inflammation and an eosinophil chemoattractant were compared with clinical measures used in CRS.</p> </sec> <sec id="alr21082-sec-0020" sec-type="section"> <title>Methods</title> <p>Sinus mucosal samples from CRS patients undergoing sinus surgery were analyzed for interleukin‐25 (IL‐25), IL‐33, thymic stromal lymphopoietin (TSLP), and eotaxin‐3 messenger RNA (mRNA) expression by quantitative polymerase chain reaction (PCR). Tumor patients undergoing surgery transnasally with normal sinus mucosa were controls. Gene expression was compared with symptom, radiology, and endoscopy scores, serological markers, presence of reactive airways disease (RAD), and atopy.</p> </sec> <sec id="alr21082-sec-0030" sec-type="section"> <title>Results</title> <p>Thirty‐seven patients (38% female, mean age 48 ± 15 years), 12 CRS with nasal polyps (CRSwNP), 18 CRS without nasal polyps (CRSsNP), and 7 controls were recruited. CRSwNP phenotype predicted elevated IL‐25, IL‐33, and eotaxin‐3 levels. Increased eotaxin‐3 correlated with poorer computed tomography (CT) (<italic>p</italic> = 0.004) and endoscopic scores (<italic>p</italic> = 0.049). Increased IL‐25 correlated with poorer CT scores (<italic>p</italic> = 0.012) and raised serum eosinophils (<italic>p</italic> = 0.006). No associations with RAD, atopy, and symptom measures were found. No associations for IL‐33 and TSLP were found.</p> </sec> <sec id="alr21082-sec-0040" sec-type="section"> <title>Conclusion</title> <p>Inflammatory mediators of the epithelium in CRS has some correlation with traditional measures of disease burden. Certain epithelial profiles may predict highly dysfunctional epithelial barriers and prospective evaluation of the clinical outcomes from interventions is required. Future endotyping of the epithelium in CRS may be able to provide prognostic information.</p> </sec> </abstract>